Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).
How is the business of making medicine changing in light of the COVID-19 pandemic?
Sitting Down With... JoyL Silva, General Manager at PfizerCentre.
Sitting Down With... Kelly Chibale, Director, H3D, University of Cape Town, South Africa.
Business insurance exists to help companies when unexpected events and damages occur – so you need to have the right policy in place.
What makes pharma so good at rebranding?
Pfizer is supporting homelearners amid the COVID-19 pandemic.
How has the COVID-19 pandemic changed the industry? And how can we respond faster next time?
Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.